Search results
Results From The WOW.Com Content Network
Obecabtagene autoleucel, sold under the brand name Aucatzyl, is an anti-cancer medication used for the treatment of acute lymphoblastic leukemia. [1] [2] It is a CD19-directed genetically modified autologous T-cell immunotherapy.
Sulopenem/probenecid, sold under the brand name Orlynvah, is a fixed-dose combination medication used for the treatment of urinary tract infections. [1] It contains sulopenem, a penem antibacterial, as the prodrug sulopenem etzadroxil; and probenecid, a renal tubular transport inhibitor.
In January 2019, 30 years after its publication, Lyte collaborated on the Positive K single "I'm Still Not Havin 'It", which is a continuation of the original version. "I find it incredible that after 30 years MC Lyte and I haven’t skipped a beat” Positive K said in a press release. “We have just as much chemistry now as we did then.
Anyone with information about the case or knows the baby's whereabouts is asked to call 911 or the sheriff's office at 205-932-3205. Natalie Neysa Alund is a senior reporter for USA TODAY. Reach ...
Positive K (sometimes stylized as +K) (born Darryl Gibson on August 9, 1967) is an American MC and songwriter from the Bronx, New York City, New York, and one of the original artists of the First Priority Music camp. He is best known for his hits "I'm Not Havin' It" (a duet with MC Lyte) and his 1992 hit "I Got a Man". [1]
This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Bright, fresh produce might not be the first thing that comes to mind when winter rolls around. But this time of year, you can say ...
"Online gambling companies have lots, tons of data about their players because every single bet or every spin on a slot, every single deposit, the time you spend online, there's lots of ...
Zenocutuzumab is indicated for the treatment of adults with advanced, unresectable or metastatic non-small cell lung cancer harboring a neuregulin 1 gene fusion with disease progression on or after prior systemic therapy; adults with advanced, unresectable or metastatic pancreatic adenocarcinoma harboring a neuregulin 1 gene fusion with disease progression on or after prior systemic therapy.